[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news

New Imaging Score May Predict Chemo Benefit in Early OPSCC New Imaging Score May Predict Chemo Benefit in Early OPSCC
If validated, this scoring system could help identify patients with oropharyngeal squamous cell carcinoma who can skip chemo. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Deep Learning Model Aids Differentiation of Colon Cancer, Acute Diverticulitis
FRIDAY, Jan. 27, 2023 -- A three-dimensional (3-D) convolutional neural network (CNN) can be used as an artificial intelligence (AI) support system for differentiating colon carcinoma (CC) and acute diverticulitis (AD) on computed tomography (CT)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2023 Category: Pharmaceuticals Source Type: news

Mum Sarah O'Brien diagnosed with skin cancer after driving without wearing sunscreen
Sydney mum Sarah O'Brien was diagnosed with Basal Cell Carcinoma (BCC) in May 2022. In February she noticed a small lump appeared on her right temple. (Source: the Mail online | Health)
Source: the Mail online | Health - January 27, 2023 Category: Consumer Health News Source Type: news

Palliative Radiotherapy Reduces End-Stage Liver Cancer Pain Palliative Radiotherapy Reduces End-Stage Liver Cancer Pain
Most patients with end-stage hepatocellular carcinoma experience pain; a new study shows that low-dose radiotherapy can relieve pain and even improve survival.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Risk for Subsequent Facial Keratinocyte Carcinoma Lower With Laser Treatment
TUESDAY, Jan. 24, 2023 -- For patients with a history of facial keratinocyte carcinoma (KC), nonablative fractional laser (NAFL) treatment is associated with a reduced risk for subsequent development of facial KC, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2023 Category: Pharmaceuticals Source Type: news

PSMA-PET matches MRI, beats CT in diagnosing liver cancer
Prostate-specific membrane antigen (PSMA) PET/CT appears equivalent to MRI an...Read more on AuntMinnie.comRelated Reading: CT radiomics helps predict HCC recurrence after liver transplant New tracer bests FDG for diagnosing liver cancer PET identifies early responders to liver cancer treatment AI can identify hepatocellular carcinoma on liver CT exams (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 23, 2023 Category: Radiology Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
Pivotal Phase III IMbrave050 study investigatingTecentriq plusAvastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free survivalNew adjuvant treatments are urgently needed as an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery1Data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency to inform the next regulatory steps, and presented at an upcoming medical meetingBasel, 19 January 2023 - Roche (SIX: RO, ROG;...
Source: Roche Investor Update - January 19, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
Pivotal Phase III IMbrave050 study investigatingTecentriq plusAvastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free survivalNew adjuvant treatments are urgently needed as an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery1Data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency to inform the next regulatory steps, and presented at an upcoming medical meetingBasel, 19 January 2023 - Roche (SIX: RO, ROG;...
Source: Roche Media News - January 19, 2023 Category: Pharmaceuticals Source Type: news

Jill Biden's Cancer Surgery; Gurney Suffocation Death; Dollar General Clinics
(MedPage Today) -- Note that some links may require subscriptions. First Lady Jill Biden had two cancerous lesions -- both basal cell carcinomas -- successfully removed on Wednesday. (NBC News) The Biden administration again renewed the COVID... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - January 12, 2023 Category: Dermatology Source Type: news

What Is basal cell carcinoma? Jill Biden has cancerous lesions removed
First lady Jill Biden has been diagnosed with basal cell carcinoma following the removal of at least two cancerous skin lesions. Biden had three lesions removed during surgery at Walter Reed National Military Medical Center on Wednesday. The procedure was announced last week following the…#skincancerfoundation #twitter #vanessavaldivia #oconnor #jillbiden #kevinoconnor (Source: Reuters: Health)
Source: Reuters: Health - January 12, 2023 Category: Consumer Health News Source Type: news

What to know about the kind of skin cancer Jill Biden was treated for
The skin cancer first lady Jill Biden was treated for Wednesday — basal cell carcinoma — is highly treatable and the most common form of skin cancer. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - January 12, 2023 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

Half of DCIS-treated women don't get ongoing imaging surveillance
More than half of women treated for ductal carcinoma in situ (DCIS) do not consistentl...Read more on AuntMinnie.comRelated Reading: Is palpable DCIS more aggressive than screen-detected? Ultrafast MRI shows promise in predicting DCIS upstaging Screening breast imaging findings differ between Black and white women Ultrasound guidance effective in DCIS surgery DWI-MRI predicts whether women's DCIS will upstage after surgery (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 11, 2023 Category: Radiology Source Type: news

Holistic Management Of Hepatocellular Carcinoma Holistic Management Of Hepatocellular Carcinoma
The authors highlight the need for a team-based holistic approach to the patient with hepatocellular carcinoma, presenting a practical playbook for management of patients with liver disease and HCC.Liver International (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - January 6, 2023 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news